Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Review.

Literature DB >> 21960834

Review.

Sujal Rangwalla¹, Cheryl E Gariepy.

Abstract

Year: 2007 PMID： 21960834 PMCID： PMC3099342

Source DB: PubMed Journal: Gastroenterol Hepatol (N Y) ISSN： 1554-7914

Keyword Cloud
References

× No keyword cloud information.

23 in total

1. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Authors: H Joensuu; P J Roberts; M Sarlomo-Rikala; L C Andersson; P Tervahartiala; D Tuveson; S Silberman; R Capdeville; S Dimitrijevic; B Druker; G D Demetri
Journal: N Engl J Med Date: 2001-04-05 Impact factor: 91.245

Review 2. The RET proto-oncogene: a potential target for molecular cancer therapy.

Authors: Brigitte M Pützer; Matthias Drosten
Journal: Trends Mol Med Date: 2004-07 Impact factor: 11.951

3. Oral Mucosal Neuromas Leading to the Diagnosis of Multiple Endocrine Neoplasia Type 2B in a Child With Intestinal Pseudo-obstruction.

Authors: Cary M Qualia; Marilyn R Brown; Charlotte K Ryan; Thomas M Rossi
Journal: Gastroenterol Hepatol (N Y) Date: 2007-03

4. Inhibition of Ret oncogene activity by the protein tyrosine phosphatase SHP1.

Authors: A M Hennige; R Lammers; W Höppner; D Arlt; V Strack; R Teichmann; F Machicao; A Ullrich; H U Häring; M Kellerer
Journal: Endocrinology Date: 2001-10 Impact factor: 4.736

5. The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis.

Authors: B Mograbi; R Bocciardi; I Bourget; T Juhel; D Farahi-Far; G Romeo; I Ceccherini; B Rossi
Journal: Mol Cell Biol Date: 2001-10 Impact factor: 4.272

Review.

1. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Review 2. The RET proto-oncogene: a potential target for molecular cancer therapy.

3. Oral Mucosal Neuromas Leading to the Diagnosis of Multiple Endocrine Neoplasia Type 2B in a Child With Intestinal Pseudo-obstruction.

4. Inhibition of Ret oncogene activity by the protein tyrosine phosphatase SHP1.

5. The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis.

Review 6. The GDNF/RET signaling pathway and human diseases.

7. Improved gene transfer to neuroblastoma cells by a monoclonal antibody targeting RET, a receptor tyrosine kinase.

Review 8. RET tyrosine kinase signaling in development and cancer.

9. Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.

10. Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations.